Advances and controversies in etiopathogenesis of type 1 (insulin- dependent) diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue SUPPL. 2, 1998, Pages 293-305

  Bosi, Emanuele ^a   Sarugeri, Elena ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

CONFERENCE PAPER; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PATHOGENESIS; PREDICTION; SEQUENCE HOMOLOGY; VIRUS ISOLATION;

ANIMALS; AUTOIMMUNE DISEASES; CATTLE; DIABETES MELLITUS, TYPE 1; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL ILLNESS; GENES, MHC CLASS II; HUMANS; INCIDENCE; MILK; RISK FACTORS; VIRUS DISEASES;

EID: 0031797544     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (139)

1. Todd JA. The role of MHC class II genes in type 1 diabetes. Curr Topics Microb Immunol 1990; 164: 17-40.
2. Nepom GT. Immunogenetics and IDDM. Diabetes Rev 1993; 1: 93-103.
3. Todd JA, Bell JI, McDevitt HO. HLA-DQβ gene contribute to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599-604.
4. Khalil H, D'Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Park MS, Degos L, Galibert F, Hors J. A combination of HLA-DQβ Asp 57-negative and HLA-DQα Arg 52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 1990; 85: 1315-1319.
5. Caillat-Zucman S, Bertin E, Timsit J, Boitard C, Assan R, Bach JF. Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur J Immunol 1993; 23: 1784-1788.
6. Martinez-Laso J, Martin-Villa JM, Alvarez M, Martin-Villa JM, Alvarez M, Martinez-Quiles N, Lledo G, Arnaiz-Villena A. Susceptibility to insulin-dependent diabetes mellitus and short cytoplasmic ATP-binding domain TAP2*01 alleles. Tissue Antigens 1994; 44: 184-188.
7. Ronningen KS, Undlien DE, Ploski R, Maouni N, Konrad RJ, Jensen E, Homes E, Reijonen H, Colonna M, Monos DS, Strominger J, Thorsby E. Linkage disequilibrium between TAP2 variants and HLA class II alleles: no primary association between TAP2 variants and insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 1050-1056.
8. Cucca F, Congia M, Trowsdale J, Powis SH. Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: no association in a population with a high disease incidence. Tissue Antigens 1994; 44: 234-240.
9. Esposito L, Lampasona V, Bosi E, Poli F, Ferrari M, Bonifacio E. HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus. Diabetologia 1995; 38: 968-974.
10. Deng GY, Muir A, Maclaren NK, She JX. Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Genet 1995; 56: 528-534.
11. Van Endert PM, Liblau RS, Patel SD, Fugger L, Lopez T, Pociot F, Nerup J, McDevitt HO. Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM. Diabetes 1994; 43: 110-117.
12. Kawaguchi Y, Ikegami H, Fukuda M, Takekawa K, Fujioka Y, Fujisawa T, Ueda H, Ogihara T. Absence of association of TAP and LMP genes with type 1 (insulin-dependent) diabetes mellitus. Life Sci 1994; 54: 2049-2053.
13. Undlien DE, Akselsen HE, Joner G, Dahl-Jorgensen K, Sovik O, Ronningen KS, Thorsby E. No independent associations of LMP2 and LMP7 polymorphisms with susceptibility to develop IDDM. Diabetes 1997; 46: 307-312.
14. Djiali-Saiah I, Benini V, Schmitz J, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Absence of primary association between DM gene polymorphism and insulin-dependent diabetes mellitus or celiac disease. Hum Immunol 1996; 49: 22-27.
15. Esposito L, Lampasona V, Bonifacio E, Bosi E, Ferrari M. Lack of association of DMB polymorphism with insulin dependent diabetes. J Autoimmun 1997; 10: 395-400.
16. Bennet ST, Lucassen AM, Gough SCL, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Ronningen KS, Barnett AH, Bain SC, Todd JA. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 1995; 9: 284-292.
17. Undlien DE, Bennet ST, Todd JA, Akselsen HE, Ikaheimo I, Reijonen H, Knip M, Thorsby E, Ronningen KS. Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes 1995; 44: 620-625.
18. Davies JL, Kawaguchi Y, Bennet ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, Todd JA. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-136.
19. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85: 311-318.
20. Luo D, Bui MM, Muir A, Maclaren NK, Thomson G, She J. Affected sib-pair mapping of a novel susceptibility gene to insulin dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet 1995; 57: 911-919.
21. Luo D, Buzzetti R, Rotter JI, Maclaren NK, Raffel LJ, Nisticò L, Giovannini C, Pozzilli P, Thomson G, She JX. Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and JDDM8. Hum Mol Genet 1996; 5: 693-698.
22. Davies JL, Cucca F, Goy JV, Atta ZAA, Merriman ME, Wilson A, Barnett AH, Bain SC, Todd JA. Saturation multipoint linkage mapping of chromosome 6q in type 1 diabetes. Hum Mol Genet 1996; 5: 1071-1074.
23. Merriman T, Twells R, Merriman M, Eaves I, Cox R, Cucca F, McKinney P, Shield J, Baum D, Bosi E, Pozzilli P, Nisticò L, Buzzetti R, Joner G, Ronningen K, Thorsby E, Undlien D, Pociot F, Nerup J, Bain S, Barnett A, Todd JA. Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet 1997; 6: 1003-1010.
24. Reed PW, Cucca F, Jenkins S, Merriman M, Wilson A, McKinney P, Bosi E, Joner G, Ronningen KS, Thorsby E, Undlien DE, Merriman T, Barnett AH, Bain SC, Todd JA. Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. Hum Mol Genet 1997; 6: 1011-1016.
25. Copeman JB, Cucca F, Heame CM, Cornall RJ, Reed PW, Ronningen KS, Undlien DE, Nisticò L, Buzzetti R, Tosi R, Pociot F, Nerup J, Cornelis F, Barnett AH, Bain SC, Todd JA. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 1995; 9: 80-85.
26. Luo D, Maclaren NK, Huang H, Muir A, She J. Intrafamilial and case-control association analysis of D2S152 in insulin dependent diabetes mellitus. Autoimmunity 1995; 21: 143-147.
27. Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Martinez-Larrad MT, Serrano-Rios M, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Belgian Diabetes Registry, Tosi R, Pozzilli P, Todd JA. The CTLA-4 gene region contains a mutation that predisposes to type 1 diabetes. Hum Mol Genet 1996; 5: 1075-1080.
28. Morahan G, Huang D, Tait BD, Colman PG, Harrison LC. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 1996; 272: 1811-1813.
29. Owerbach D, Gabbay KH. The HOXD8 locus (2q31) is linked to type 1 diabetes. Diabetes 1995; 44: 132-136.
30. Rowe RE, Wapelhorst B, Bell GI, Risch N, Spielman RS, Concannon P. Linkage and association between insulin-dependent diabetes mellitus (IDDM) susceptibility and markers near the glucokinase gene on chromosome 7. Nat Genet 1995; 10: 240-242.
31. Field LL, Tobias R, Thomson G, Plon S. Susceptibility to insulin dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3-q31. Genomics 1996; 33: 1-8.
32. Green A, Gale EAM, Patterson CC for the EURODIAB ACE Study Group. Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study Group. Lancet 1992; 339: 905-909.
33. Patterson CC, Carson DJ, Hadden DR. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Diabetologia 1996; 39: 1063-1069.
34. Borch-Johnsen K, Joner G, Mandrup-Poulsen T, Christy M, Zachau-Christiansen B, Kastrup K, Nerup J. Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. Lancet 1984; II: 1083-1086.
35. Gerstein IIC. Cow's milk exposure and type I diabetes mellitus. Diabetes Care 1994; 17: 13-19.
36. Norris JM, Scott FW. A meta-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role? Epidemiology 1996; 7: 87-92.
37. Karjalainen J, Martin JM, Knip M, Ilonen S, Robinson BH, Savilahti E, Akerblom HK, Dosch HM. Evidence for a bovine albumin peptide as a candidate trigger of type 1 diabetes. N Engl J Med 1992; 327: 302-307.
38. Dahlquist G, Savilathi E, Landin-Olsson M. An increased level of antibodies to β-lactoglobulin is a risk determinant for early-onset type 1 (insulin-dependent) diabetes mellitus independent of islet cell antibodies and early introduction of cow's milk. Diabetologia 1992; 35: 980-984.
39. Cheung R, Karjalainen J, Vandermeulen J, Singal DP, Dosch HM. T cells from children with IDDM are sensitized to bovine serum albumin. Scand J Immunol 1993; 40: 623-628, 1993.
40. Miyazaki I, Cheung RK, Gaedigk R, Hui MF, Van der Meulen J, Rajotte RV, Dosch HM. T cell activation and allergy to islet cell antigen in type 1 diabetes. J Immunol 1995; 154: 1461-1469.
41. Vaarala O, Klemetti P, Savilahti E, Reijonen H, Ilonen J, Akerblom HK. Cellular immune response to cow's milk β-lactoglobulin in patients with newly diagnosed IDDM. Diabetes 1996; 45: 178-182.
42. Cavallo MG, Monetini L, Barone F, Barone MG, Fava D, Valente L, Pozzilli P. Cell-mediated and humoral immune responses to beta casein in IDDM. Autoimmunity 1996; 24: 12 (abstract).
43. Cavallo MG, Fava D, Monetini L, Barone F, Pozzilli P. Cell-mediated immune response to β-casein in recentonset insulin-dependent diabetes: implications for disease pathogenesis. Lancet 1996; 348: 926-928.
44. Atkinson MA, Bowman MA, Kao KJ, Campbell L, Dush PJ, Shah SC, Sirnell O, Maclaren NK. Lack of immune responsivness to bovine serum albumin in insulin dependent diabetes. N Engl J Med 1993; 329: 1853-1858.
45. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo YL, Martin S, Martin A, Powers AC, Prochazka M, Naggert J, Lester GH, Eisenbarth GS. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen: J Clin Invest 1993; 92: 359-371.
46. Lampasona V, Ferrari M, Bosi E, Pastore RM, Bingley PJ, Bonifacio E. Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen. J Autoimmun 1994; 7: 665-674.
47. Martin S, Kardorf J, Schulte B, Lampeter EF, Gries FA, Melchers I, Wagner R, Bertrams J, Roep BO, Pfutzner A, Pietropaolo M, Kolb H. Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia 1995; 38: 351-355.
48. Yoon JW. A new look at viruses in type 1 diabetes. Diab Metab Rev 1995; 11: 83-107.
49. Gamble DR, Taylor KW. Seasonal incidence of diabetes mellitus. Br Med J 1969; 2: 631-633.
50. Harris HF. A case of diabetes mellitus quickly following mumps. On the pathological alterations of salivary glands, closely resembling those found in pancreas, in a case of diabetes mellitus. Boston Med Surg J 1899; 140: 465-469.
51. Yoon JW. Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300: 1173-1179.
52. Lévy-Marchal C, Patterson C, Green A on behalf of the EURODIAB ACE Study Group. Variation by age group and seasonality at diagnosis of childhood IDDM in Europe. Diabetologia 1995; 38: 823-830.
53. Bodanski HJ, Littlewood JM, Bottazzo GF, Dean BM, Hambling MH. Which virus causes the initial islet lesion in type I diabetes? Lancet 1984; I: 401-402.
54. Banatvala J, Schernthaner G, Schober E, De Silva LM, Bryant J, Borkenstein M, Brown D, Menser MA, Silink M. Coxsackie B, mumps, rubella and cytomegalovirus specific IgM responses in patients with juvenile onset insulin dependent diabetes mellitus in Britain, Austria and Australia. Lancet 1985; I: 1409-1412.
55. D'Alessio DJ. A case-control study of group B Coxsackie virus immunoglobulin IgM antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 1992; 135: 1331-1338.
56. Frisk G, Friman G, Tuvemo T, Fohlman J, Diderholm H. Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Diabetologia 1992; 35: 249-253.
57. Tuvemo T, Dahlquist G, Frisk G, Blom L, Friman G, Landin-Olsson M, Diderholm H. The Swedish childhood diabetes study III: IgM against Coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children - no evidence of increased antibody frequency. Diabetologia 1989; 32: 745-747.
58. Dahlquist G, Frisk G, Ivarsson SA, Svanberg L, Forgsen M, Diderholm H. Indications that maternal Coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 1995; 38: 1371-1373.
59. Dahlquist G, Ivarsson SA, Lindberg B, Forgsen M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes 1995; 44: 408-413.
60. Hyoty H, Hiltunen M, Knip M, Laakkonen M, Vahasalo P, Karjalainen J, Koskela P, Roivainen M, Leinikki P, Hovi T, Akerblom HK and the Childhood Diabetes in Finland (DiMe) Study Group. A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44: 652-657.
61. Graves PM, Norris JM, Pallansch MA, Gerling IC, Rewers M. The role of enteroviral infections in the development of IDDM: limitations and current approaches. Diabetes 1997; 46: 161-168.
62. Clemens GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995; 346: 221-223.
63. Foulis AK, McGill M, Farquharson MA, Hilton DA. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 1997; 40: 53-61.
64. Yoon JW, McClintock PR, Bachurski CJ, Longstreth JD, Notkins AL. Virus-induced diabetes mellitus. No evidence for immune mechanisms in the destruction of beta cells by encephalomyocarditis virus. Diabetes 1985; 34: 922-925.
65. Kaufman DL, Erlander MG, Clare-Salzer M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283-292.
66. Hou J, Said C, Franchi D, Dockstader P, Chatterejee NK. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from Coxsackie virus B4-infected mice and IDDM patients. Diabetes 1994; 43: 1260-1266.
67. Atkinson MA, Bowman MA, Campbell L, Darrow B, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994; 94: 2125-2129.
68. Richter W, Mertens T, Schoel B, Muir P, Ritzkowsky A, Scherbaum WA, Boehm BO. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with Coxsackie B4-2C protein and heat shock protein mediates no molecular mimicry of autoantibodies. J Exp Med 1994; 180: 721-726.
69. Foulis AK, Farquharson MA, Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1987; II: 1423-1427.
70. Huang X, Yuan J, Goddard A, Foulis A, James RFL, Lernmark A, Pujol-Borrell R, Rabinovitch A, Somoza N, Stewart TA. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 1995; 44: 658-664.
71. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 25-36.
72. Pak CY, Eun HM, McArthur RG, Yoon JW. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 1988; II: 1-4.
73. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriguez-Rilo H, Finegold D, Trucco M. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994; 371: 351-355.
74. Acha-Orbea H, Palmer E. Mls-a retrovirus exploits the immune system.Immunol Today 1991; 12: 356-361.
75. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997; 90: 303-313.
76. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1995; 15: 516-542.
77. null mice. J Exp Med 1996; 184: 2049-2053.
78. Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 1997; 46: 941-946.
79. Bosi E, Bonifacio E. Autoantibodies in insulin-dependent diabetes mellitus. J Endocrinol Invest 1994; 17: 521-531.
80. Bingley PJ, Bonifacio E, Gale EAM. Can we really predict IDDM? Diabetes 1993; 42: 213-220.
81. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet 1974; II: 1279-1283.
82. Skyler JS, Marks JB. Immune intervention in type 1 diabetes mellitus. Diabetes Rev 1993; 1: 15-42.
83. Harrison LC. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today 1992; 13: 348-352.
84. Bosi E, Bonifacio E, Bottazzo GF. Autoantigens in IDDM. Diabetes Rev 1993; 1: 204-214.
85. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-1339.
86. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-156.
87. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, Rae PMM. Islet cell antigen 512 is a diabetes-specific autoantigen related to protein tyrosine phosphatases. J Immunol 1994; 152: 3183-3188.
88. Lu J, Li Q, Xie H, Chen ZJ, Borovitskaya AE, Maclaren NK, Notkins AL, Lan MS. Identification of a second transmembrane protein tyrosine phosphatase IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 1996; 93: 2307-2311.
89. Baekkeskov S, Nielson JH, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human islet cell protein. Nature 1982; 298: 167-169.
90. Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL. Distinct antibody specificities to a 64-kD islet cell antigen in type I diabetes as revealed by trypsin treatment. J Exp Med 1990; 172: 789-795.
91. r tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 1995; 96: 1506-1511.
92. Passini N, Larigan DG, Genovese S, Appella E, Sinigaglia F, Rogge L. The 37/40-kilodalton autoantigen in insulin dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc Natl Acad Sci USA 1995; 92: 9412-9416.
93. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. Identification of protein tyrosine phosphatase-like IA-2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 1995; 155: 5419-5426.
94. Hawkes CJ, Wasmeier C, Christie MR, Hutton JC. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (Phogrin) related to IA-2. Diabetes 1996; 45: 1187-1192.
95. Genovese S, Bonifacio E, McNally J, Wagner R, Dean BM, Bosi E, Gale EAM, Bottazzo GF. Distinct cytoplasmic islet cell antibodies with different risks for type I (insulin dependent) diabetes. Diabetologia 1992; 35: 385-389.
96. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 1993; 91: 350-356.
97. Marshall MO, Moyer PE, Petersen JS, Hejnaes KR, Genovese S, Dyrberg T, Bottazzo GF. Contribution of glutamate decarboxylase antibodies to the reactivity of cytoplasmic islet cell antibodies. J Autoimmun 1994; 7: 497-501.
98. Myers MA, Rabin DU, Rowley MJ. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 1995; 44: 1290-1295.
99. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale AEM, Bosi E. Islet autoantibody markers in insulin dependent diabetes: risk assessment strategies yielding high sensitivity. Diabetologia 1995; 38: 816-822.
100. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark A. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995; 95: 1505-1511.
101. Bonifacio E, Bingley PJ, Dean BM, Shattock M, Dunger D, Gale EAM, Bottazzo GF. Quantification of islet cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147-149.
102. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, Rotter JI. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990; 323: 1167-1172.
103. + relatives. Diabetes 1996; 45: 1720-1728.
104. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EAM. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304-1310.
105. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45: 926-933.
106. Seissler J, Morgenthaler NG, Achenbach P, Lamperter EF, Glawe D, Payton M, Christie M, Scherbaum WA and the DENIS Study Group. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 1996; 39: 1351-1356.
107. Genovese S, Bingley PJ, Bonifacio E, Christie MR, Shattock M, Bonfanti R, Foxon R, Gale EAM, Bottazzo GF. Combined analysis of IDDM-related autoantibodies in healthy schoolchildren. Lancet 1994; 344: 756.
108. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG, Belgian Diabetes Registry. IA-2 autoantibodies complement GAD65-autoantibodies in new onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 1997; 40: 95-99.
109. Roep BO. T-cell responses to autoantigens in IDDM. The search for the holy grail. Diabetes 1996; 45: 1147-1156.
110. MacCuish AC, Jordan J, Campbell CJ, Duncan LJ, Irvine WJ. Cell-mediated immunity in diabetes mellitus: lymphocyte transformation by insulin and insulin fragments in insulin-treated and newly-diagnosed diabetes. Diabetes 1975; 24: 36-43.
111. Miller GG, Pollack MS, Nell LJ, Thomas JW. Insulin-specific human T-cells. J Immunol 1987; 139: 3622-3629.
112. Naquet P, Ellis J, Tibensky D, Kenshole A, Singh B, Hodges R, Delovitch TL. T cell autoreactivity to insulin in diabetic and related non diabetic individuals. J Immunol 1988; 140: 2569-2578.
113. Keller RJ. Cellular immunity to human insulin in individuals at high risk for the development of type 1 diabetes mellitus. J Autoimmun 1990; 3: 321-327.
114. Harrison LC, De Aizpurua H, Loudovaris T, Campbell IL, Cebon JS, Tait BD, Colman PG. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes 1991; 40: 1128-1133.
115. Harrison LC, Chu SX, De Aizpurua HJ, Graham M, Honeyman MC, Colman PG. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J Clin Invest 1992; 89: 1161-1165.
116. Sarugeri E, Dozio N, Belloni C, Meschi F, Bonifacio E, Pozza G. Lymphocyte proliferation against insulin in newly diagnosed IDDM patients. Diabetologia 1995; 38 (Suppl 1): A80 (abstract).
117. Sarugeri E, Belloni C, Dozio N, Meschi F, Pastore MR, Bazzigaluppi E, Tubiello G, Bonifacio E. Relationship between cellular and humoral immune responses to islet autoantigens. Autoimmunity 1995; 21 (Suppl): 27 (abstract).
118. Durinovic-Bellò I, Hummel M, Ziegler AG. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 1996; 45: 795-800.
119. Rudy G, Stone N, Harrison LC, Colman PG, McNair P, Brusic V, French MB, Honeyman MC, Tait B, Lew AM. Similar peptides from two β-cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med 1995; 1: 625-633.
120. Sarugeri E, Dozio N, Meschi F, Pastore MR, Bosi E, Bonifacio E. T cell responses to IDDM autoantigen peptides sharing homologous regions. Diabetologia 1997; 40 (Suppl 1): A87 (abstract).
121. Honeyman MC, Cram DS, Harrison LC. Glutamic acid decarboxylase 67 reactive T cells: a marker of insulin dependent diabetes. J Exp Med 1993; 177: 535-540.
122. Lohmann T, Leslie RDG, Hawa M, Geysen M, Rodda S, Londei M. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin dependent diabetes mellitus. Lancet 1994; 343: 1607-1608.
123. Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin dependent diabetes. Lancet 1993; 341: 1365-1369.
124. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF, Erlander MG, Tobin AJ, Maclaren NK. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992; 339: 458-459.
125. DeAizpurua HJ, Honeyman MC, Harrison LC. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes. J Autoimmun 1992; 5: 759-770.
126. Schloot NC, Roep BO, Wegman DR, Yu L, Wang TB, Eisenbarth GS. T-cell reactivity to GAD65 peptide sequences shared with Coxackie virus protein in recentonset IDDM, post-onset IDDM patients and control subjects. Diabetologia 1997; 40: 332-338.
127. Armstrong NW, Jones DB. Epitopes of GAD65 in insulin-dependent diabetes. Lancet 1994; 344: 406-407.
128. Roep BO, Arden SD, De Vries RRP, Hutton JC. T-cell clones from a type 1 diabetes patient respond to insulin secretory granule proteins. Nature 1990; 345: 632-634.
129. Roep BO, Kallan AA, Hazenbos WL, Bruining GJ, Bailyes EM, Arden SD, Hutton JC, De Vries RRP. T-cell reactivity to 38kD insulin secretory granule protein in patients with recent onset type 1 diabetes. Lancet 1991; 337: 1439-1441.
130. Arden SD, Roep BO, Neophytou PI, Usac EF, Duinkerken G, De Vries RR, Hutton JC. Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patients. J Clin Invest 1996; 97: 551-561.
131. Honeyman MC, Cram DS, Harrison LC. Transcription factor Jun-B is target of autoreactive T-cells in IDDM. Diabetes 1993; 42: 626-630.
132. Roep BO, Duinkerken G, Schreuder GMT, Kolb H, De Vries RRP, Martin S. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol 1996; 26: 1285-1289.
133. Jones DB, Crosby I. Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia 1996; 39: 1318-1324.
134. Roep BO, Kallan AA, Duinkerken G, Arden SD, Hutton JC, Bruining GJ, DeVries RR. T-cell reactivity to beta cell membrane antigens associated with beta cell destruction in IDDM. Diabetes 1995; 44: 278-283.
135. Van Vliet E, Roep BO, Meulenbroek L, Bruining GJ, De Vries RR. Human T cell clones with specificity for insulinoma cell antigens. Eur J Immunol 1989; 19: 213-216.
136. Ellis TM, Darrow B, Campbell L, Atkinson MA. Inverse relationship between humoral and cellular immune responses to glutamate decarboxylase 65 (GAD) and insulin in IDDM. Diabetes 1995; 44 (Suppl 1): 52A (abstract).
137. Hummel M, Durinovic-Bellò I, Ziegler AG. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. J Autoimmun 1996; 9: 427-430.
138. Schlott NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, Eisenbarth GS. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 1997; 40: 564-572.
139. Nerup J, Andersen OO, Bendixen G, Egeberg J, Poulsen JE. Antipancreatic cellular hypersensitivity in diabetes mellitus. Diabetes 1971; 20: 424-427.